New strategy aims to stop bone loss when switching osteoporosis treatments
NCT ID NCT05655013
Summary
This study is testing whether a different medication, zoledronate, given as an infusion, can help maintain bone density in women who are stopping their current osteoporosis treatment, denosumab. It involves 200 postmenopausal women who have been on denosumab for at least two years. Researchers want to see if giving zoledronate at specific times or based on blood tests can prevent the bone loss that often happens when stopping denosumab.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS, POSTMENOPAUSAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus University Hospital
Aarhus, Denmark
Conditions
Explore the condition pages connected to this study.